MBP metabolic pharmaceuticals limited

new research report 9th july

  1. 259 Posts.
    A new research report from a New York based co. Emerging Market Equity Research dated July 1st released today can be read at www.metabolic.com.au under the broker reseach section. They have a 12 month price target of $1.97.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.